Ruijuan Gao

880 citations
42 papers · 615 indexed · h-index 15
Topics
Monoclonal and Polyclonal Antibodies Research (7 papers)HER2/EGFR in Cancer Research (5 papers)Cancer, Hypoxia, and Metabolism (5 papers)

In The Last Decade

Ruijuan Gao

40 papers receiving 607 citations

Peers

Ruijuan Gao
Comparison fields: 5 of 98
  • Molecular Biology 269
  • Oncology 115
  • Radiology, Nuclear Medicine and Imaging 83
  • Immunology 71
  • Materials Chemistry 66
Replace Yoshinobu Odaka with:
Yoshinobu Odaka United States
Gajanan Sathe India
Tadahiro Nakamura Japan
Kohta Kurohane Japan
Gwenda Pynaert Belgium
Emmanuelle Mouton‐Barbosa France
Suresh Selvaraj India
Mingjiao Sun China
Ruijuan Gao relative to Yoshinobu Odaka United States Yoshinobu Odaka's profile →
Citations per field
00.5×11×
Yoshinobu Odaka · 1×
Citations per year

Countries citing papers authored by Ruijuan Gao

Since Specialization
Citations

This map shows the geographic impact of Ruijuan Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruijuan Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruijuan Gao more than expected).

Fields of papers citing papers by Ruijuan Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruijuan Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruijuan Gao. The network helps show where Ruijuan Gao may publish in the future.

Co-authorship network of co-authors of Ruijuan Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Ruijuan Gao. A scholar is included among the top collaborators of Ruijuan Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruijuan Gao. Ruijuan Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 7
3 4
4 6
5 6
6 4
7 2
8 43
9 11
10 47
11 82
12 1
13 10
14 1
15 20
16 15
17 29
18
[Binding capability of lidamycin apoprotein to human breast cancer detected by tissue microarrays].
2
19 32
20 48

About Ruijuan Gao

Ruijuan Gao is a scholar working on Biotechnology, Molecular Biology and Oncology, having authored 42 papers that have together received 615 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Ophthalmology (42 citations), Oncology (115 citations) and Molecular Biology (269 citations). Ruijuan Gao has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Rajendra Narayan Mitra, Kai Wang, Min Zheng, Zongchao Han, Yong‐Su Zhen, Chunjie Wang, Wenting Lv, Jinna Song, Xiujun Liu and Aorigele Chen. Their work appears in journals such as Journal of Clinical Investigation, ACS Nano and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026